Cooper Companies Inc (COO) CFO Sells $483,325.44 in Stock

Cooper Companies Inc (NYSE:COO) CFO Brian G. Andrews sold 1,648 shares of the firm’s stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $293.28, for a total transaction of $483,325.44. Following the transaction, the chief financial officer now owns 1,101 shares in the company, valued at $322,901.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of COO stock traded up $1.93 during mid-day trading on Friday, reaching $281.22. The stock had a trading volume of 495,475 shares, compared to its average volume of 338,807. Cooper Companies Inc has a 12-month low of $220.90 and a 12-month high of $302.36. The stock has a market cap of $13.88 billion, a P/E ratio of 24.45, a P/E/G ratio of 2.18 and a beta of 0.88. The company has a quick ratio of 0.75, a current ratio of 1.27 and a debt-to-equity ratio of 0.49.

Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Tuesday, March 5th. The medical device company reported $2.88 earnings per share for the quarter, beating analysts’ consensus estimates of $2.50 by $0.38. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. The business had revenue of $628.10 million during the quarter, compared to analysts’ expectations of $618.50 million. On average, sell-side analysts anticipate that Cooper Companies Inc will post 12.01 earnings per share for the current year.

Several brokerages recently weighed in on COO. Zacks Investment Research downgraded Cooper Companies from a “hold” rating to a “sell” rating in a report on Tuesday, February 5th. Stephens increased their price target on Cooper Companies from $305.00 to $320.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. Wells Fargo & Co increased their price target on Cooper Companies from $305.00 to $325.00 and gave the stock an “outperform” rating in a report on Wednesday, March 6th. Raymond James raised their target price on Cooper Companies from $300.00 to $325.00 and gave the company an “outperform” rating in a report on Wednesday, March 6th. Finally, Piper Jaffray Companies reissued an “overweight” rating and issued a $325.00 target price on shares of Cooper Companies in a report on Wednesday, March 6th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $307.90.

Hedge funds have recently made changes to their positions in the company. Private Advisor Group LLC bought a new position in Cooper Companies during the third quarter valued at $307,000. SG Americas Securities LLC increased its position in Cooper Companies by 76.3% during the 3rd quarter. SG Americas Securities LLC now owns 8,137 shares of the medical device company’s stock valued at $2,255,000 after purchasing an additional 3,522 shares during the period. Eagle Asset Management Inc. increased its position in Cooper Companies by 18.7% during the 3rd quarter. Eagle Asset Management Inc. now owns 2,401 shares of the medical device company’s stock valued at $665,000 after purchasing an additional 379 shares during the period. Bank of New York Mellon Corp increased its position in Cooper Companies by 1.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 408,460 shares of the medical device company’s stock valued at $113,206,000 after purchasing an additional 6,801 shares during the period. Finally, American International Group Inc. increased its position in Cooper Companies by 6.0% during the 3rd quarter. American International Group Inc. now owns 18,156 shares of the medical device company’s stock valued at $5,032,000 after purchasing an additional 1,023 shares during the period.

WARNING: “Cooper Companies Inc (COO) CFO Sells $483,325.44 in Stock” was reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/cooper-companies-inc-coo-cfo-sells-483325-44-in-stock.html.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

See Also: Bear Market

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.